CPC A61M 37/00 (2013.01) [A61B 17/00491 (2013.01); A61B 17/54 (2013.01); A61B 18/203 (2013.01); A61H 7/005 (2013.01); A61K 8/4953 (2013.01); A61K 8/63 (2013.01); A61K 8/69 (2013.01); A61K 38/4893 (2013.01); A61N 5/0617 (2013.01); A61Q 7/00 (2013.01); A45D 2200/1054 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/00495 (2013.01); A61B 2017/00734 (2013.01); A61B 2017/00747 (2013.01); A61B 2017/00761 (2013.01); A61B 2017/320004 (2013.01); A61B 2018/00476 (2013.01); A61B 2018/00577 (2013.01); A61H 23/0245 (2013.01); A61H 2201/10 (2013.01); A61H 2201/105 (2013.01); A61H 2201/1215 (2013.01); A61H 2201/1604 (2013.01); A61H 2201/1671 (2013.01); A61H 2205/021 (2013.01); A61K 2800/884 (2013.01); A61N 2005/0644 (2013.01); A61N 5/067 (2021.08)] | 14 Claims |
1. A method for treating baldness in a human subject, wherein the method comprises applying integumental perturbation to an area of the bald scalp of the human subject; wherein the integumental perturbation is performed using microneedles, and the integumental perturbation is to a skin depth of about 500 to 1000 μm, and further comprises administering minoxidil as a hair growth promoting agent.
|